BridgeBio Pharma, Inc.

BBIO Nasdaq CIK: 0001743881

Company Information

Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 3160 PORTER DR., PALO ALTO, CA, 94304
Mailing Address 3160 PORTER DR., PALO ALTO, CA, 94304
Phone (650) 391-9740
Fiscal Year End 1231
EIN 000000000

Financial Overview

FY2025

$3.01B
Total Liabilities
-$1.47B
Stockholders' Equity
$-2.88
EPS

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13D/A Beneficial ownership amendment April 2, 2026 View on SEC
8-K Current report of material events March 30, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment March 26, 2026 View on SEC
4 Insider stock transaction report March 20, 2026 View on SEC
4 Insider stock transaction report March 20, 2026 View on SEC
4 Insider stock transaction report March 19, 2026 View on SEC
4 Insider stock transaction report March 16, 2026 View on SEC
4 Insider stock transaction report March 12, 2026 View on SEC
4 Insider stock transaction report March 6, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC

Insider Trading

STRONG SELL 6 insiders 63 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2834)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.